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Abstract
Background: Although oxytocin is one of the most widely studied neuropeptides in recent times, the mechanistic process 
by which it modulates social-affective behavior in the brain is not yet clearly understood. Thus, to understand the 
neurophysiological basis of oxytocin effects, we used resting-state functional MRI to examine the effects of intranasal 
oxytocin on brain connectivity in healthy males.
Methods: Using a randomized, double-blinded, placebo-controlled, crossover design, 15 healthy male volunteers received 24 
IU intranasal oxytocin or placebo prior to resting-state functional MRI acquisition at 3T.
Results: We found that oxytocin significantly reduced the degree centrality of the right precuneus (P < .05). Oxytocin also 
reduced connectivity between the bilateral amygdalae and between the right precuneus and the right and left amygdala 
(P < .05). Although there were no significant changes in regional homogeneity at the whole brain level, posthoc results showed 
a reduction involving the right precuneus (P < .05).
Conclusions: These results show that oxytocin affects one of the key centers in the brain for social cognition and introspective 
processing, the precuneus, and enhances our understanding of how oxytocin can modulate brain networks at rest. An improved 
understanding of the neurophysiological effects of oxytocin can be important in terms of evaluating the mechanisms that are 
likely to underlie the clinical responses observed upon long-term oxytocin administration.
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Introduction
Oxytocin (OXT) is one of the most widely studied neuropep-
tides in recent times, mainly because of its potential ability 
to modulate different aspects of human social cognition such 
as emotional recognition (Shahrestani et  al., 2013), evaluation 
of trustworthiness (Lambert et  al., 2014), and fear-processing 
(Fischer-Shofty et  al., 2010; Acheson et  al., 2013). During the 
past few years, researchers have explored the use of OXT as a 
potential treatment for disorders characterized by social deficits. 
For instance, both preclinical and clinical studies have explored 
the effect of OXT on autistic spectrum disorders (Chang et al., 
2013; Gordon et  al., 2013; Teng et  al., 2013; Anagnostou et  al., 
2014), anxiety disorders (Slattery and Neumann, 2010), schizo-
phrenia (Pederson et al., 2011; Averback et al., 2012; Feifel et al., 
2012; Davis et al., 2013), and depression (MacDonald et al., 2013; 
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Mah et al., 2014). Although these studies indicate that OXT could 
be a promising therapeutic tool, the mechanism behind its mod-
ulation of social-affective behavior in the brain is not yet fully 
understood.
The neurophysiology of OXT can be evaluated in vivo using 
neuroimaging studies (Meyer-Lindenberg et  al., 2011; Zink and 
Meyer-Lindenberg, 2012; Bethlehem et  al., 2013). A  number of 
functional MRI (fMRI) studies suggest that the amygdala, an 
important social cognitive center in the brain, is a main target for 
OXT-mediated effects. Even a single-dose administration of OXT 
has a notable influence on the stimulus-induced responses and 
connectivity of the amygdala (Kirsch et  al., 2005; Domes et  al., 
2007; Domes et al., 2010; Gamer et al., 2010). However, fMRI stud-
ies have predominantly focused on the effect of OXT on blood-
oxygen-level dependent (BOLD) responses induced by stimulus 
presentation. These task-based studies differ in terms of their 
experimental design and paradigms and have also found variable 
results. Task-free assessment of brain connectivity using resting-
state fMRI can be very useful in such situations in that it would 
be possible to investigate the fundamental neurocircuitry of the 
brain without the confounding influence of task load, between-
group differences in task performance, and learning effects. To our 
knowledge, only one study so far has examined the functional con-
nectivity of the resting brain under OXT in healthy males. Sripada 
et al. (2013), using functional connectivity analysis, showed that 
the connectivity of the amygdala and the rostral medial prefrontal 
cortex might be altered by OXT (Sripada et al., 2013). Along with 
regions such as the precuneus, posterior-cingulate cortex, and lat-
eral parietal cortex, medial prefrontal cortex forms an extended 
network called the default mode network (DMN). The DMN, origi-
nally considered to be a task-negative network that contributes to 
maintaining a resting brain state, is now recognized to be relevant 
for processing social and affective stimuli in addition to its contri-
bution to self-processing (Amft et al., 2014).
Understanding the influence of OXT on the localized and 
distributed intrinsic brain connectivity patterns at rest will be 
crucial to understand how the procognitive and social effects of 
OXT are mediated. To understand the mechanisms of action of 
OXT, we looked at resting-state connectivity of the brain under 
intranasal OXT administration in male healthy volunteers. We 
studied the effect of OXT on the net connectivity of every grey-
matter voxel using voxel-wise degree centrality (DC) (Buckner 
et al., 2009) and on the localized connectivity within the neigh-
bourhood of every grey-matter voxel using regional homoge-
neity (ReHo) (Zang et al., 2004). In addition, we also tested the 
hypothesis that OXT alters the resting state functional connec-
tivity (Fc) of the amygdala with the rest of the brain, especially 
the regions constituting the DMN.
Methods
Participants
Fifteen healthy male participants were recruited for this study 
(mean age [SD]: 23.20 [4.17], range: 18–33; handedness: right = 14, 
left  =  1) via posters put up in and around the University of 
Nottingham and email messages circulated through depart-
ments. We applied the following exclusion criteria using a vol-
unteer screening telephone questionnaire: (1) lifetime history 
of substance dependence or harmful use in the past 6 months, 
(2) history of head trauma or medical conditions likely to have 
appreciable neurological or psychiatric effects, (3) personal or 
family history of psychiatric disorders, (4) contraindications for 
MRI safety assessed using a standard safety questionnaire, and 
(5) contraindications for OXT administration (eg, history of heart 
disorders, migraines, nasal problems, or known allergy to intra-
nasal applications). Participants were recruited after a clinician 
checked and approved questionnaire answers. Informed consent 
was obtained from all participants, and an inconvenience allow-
ance was paid in accordance with the ethical approval from the 
University of Nottingham Medical School Ethics Committee.
Study Design
This study employed a randomized, double-blinded, placebo-
controlled, crossover design, where all 15 participants were 
scanned on 2 different days under 2 conditions, OXT and placebo, 
with a minimum 1-week washout period between the 2 scan 
days. Conditions were randomized and counter-balanced using 
a freely available online randomizer tool, and spray bottles were 
labelled as A or B and put into envelopes that were labelled with 
participant identification and session number (1 or 2) in order to 
keep both researchers and participants blind. Participants were 
asked to not consume any alcohol for 48 hours prior to appoint-
ments and also to refrain from smoking and having any food or 
caffeinated products for 2 hours before appointments.
Participants were given either an intranasal spray of OXT (24 
IU or 40.32 mg; Syntocinon-spray; Novartis, Switzerland) or pla-
cebo (a saline nasal spray). Participants were shown how to use 
the spray and then asked to self-administer it. They were asked 
to spray 3 puffs in each nostril, each puff consisting of 4 IU, fol-
lowed by deep breaths, consistent with previous studies (Kirsch 
et al., 2005; Domes et al., 2007; Sripada et al., 2013). A 45-minute 
wait period followed the spray administration to allow for the 
maximum physiological (Kirsch et al., 2005; Domes et al., 2007) 
and pharmacokinetic effects of OXT (Born et  al., 2002). After 
this period, participants were taken to the MRI scanner where 
they completed an anatomical and a resting-state fMRI scan. 
Participants also completed the Positive and Negative Affect 
Schedule on arrival and before going into the scanner, that is, 45 
minutes after intranasal spray administration, to measure the 
behavioral effects of OXT on mood.
Image Acquisition
All scans were conducted at Sir Peter Mansfield Magnetic 
Resonance Centre, University of Nottingham using a 3T Philips 
Achieva MR Scanner (Philips Medical Systems, Best, The 
Netherlands). The resting-state fMRI acquisition lasted for 5 min-
utes, wherein participants were asked to keep their eyes open and 
focus on a fixation cross on the screen. The echo-planar images 
(EPIs) were acquired using a 32-channel head coil with SENSE fac-
tor 1 in the anterior-posterior direction, echo time (TE) of 35 ms, 
flip angle of 85°, and 240 × 240 × 112-mm field of view. A 3 × 3 mm in-
plane resolution was used with a slice thickness of 3.5 mm and a 
repetition time (TR) of 2000 ms. At each dynamic time point, a vol-
ume dataset was acquired consisting of 32 contiguous axial slices 
in descending order. Then 150 time points were acquired during 
this resting-state paradigm. An anatomical T1 MPRAGE image was 
also acquired for each subject with a 1-mm isotropic resolution, 
256 × 256 × 160 matrix, TE/TR of 2.2/4.5 ms, shot interval of 3000 ms, 
flip angle of 8°, and SENSE factor 1 for image registration.
Data Preprocessing
Resting-state data were preprocessed using Data Processing 
Assistant for Resting-State fMRI (Chao-Gan and Yu-Feng, 2010). 
The first 5 volumes of functional images were discarded to allow 
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for the stability of the longitudinal magnetization. Data were 
then slice-time corrected and spatially realigned to the first 
image of the remaining dataset. Movement parameters were 
assessed for each participant, and Friston 24 approach was used 
for correcting the effects of head motion. This model makes use 
of the 6 head motion parameters, 6 head motion parameters 
one time point before, and the corresponding 12 squared values 
(Friston et al., 1996). This has been shown to be superior to other 
model-based approaches of motion correction, particularly in 
reducing motion-BOLD relationships at the individual level (Yan 
et al., 2013). Nuisance covariates white matter and cerebrospinal 
fluid signal were regressed out before further processing.
Diffeomorphic Anatomical Registration Through Expo-
nentiated Lie algebra (DARTEL)-based normalization using each 
subject’s structural image was carried out (voxel size 3 × 3 × 3 mm), 
and the functional scans were smoothed using a Gaussian kernel 
of 8 mm full-width at half-maximum. After this, linear detrending 
and filtering using a band-pass filter (0.01–0.08 Hz) was done to 
eliminate low-frequency fluctuations and high-frequency noise. 
Finally, data were scrubbed to further correct for movement arte-
facts using frame-wise displacement (0.5 mm) (Power et al., 2012) 
with a nearest neighbor interpolation approach to further reduce 
spurious movement-induced correlations. These preprocessing 
steps were used to run the Fc and DC analyses. ReHo was initially 
computed from unsmoothed functional images in native space, 
as spatial smoothing before ReHo computation can result in a 
spurious increase in the local connectivity and ReHo intensity 
(Tian et al., 2012; Zuo et al., 2013). This was followed by detrend-
ing, band-pass filtering, spatial normalization, and smoothing 
with the same parameters as above.
In addition to the correction for frame-wise displacement, 
subjects with a high degree of head motion (>3 mm and 3 degree) 
were excluded. Two participants who formed the excluded 
group (EG) did not differ from the included group (IG) in terms of 
age (mean [SD] of EG = 23.50 [7.77] years, IG = 23.15 [3.91], P = .91) 
or intelligence quotient (mean [SD] of EG = 84.0 [12.0], IG = 96.46 
[12.46], P = .69). There was no difference between the EG and IG 
in Positive and Negative Affect Schedule within-subject change 
scores for positive affect under OXT (mean [SD] of EG = 2.00 [0.00], 
IG = 0.69 [4.15], P = .27), positive affect under placebo (mean [SD] 
of EG = −0.50 [6.36], IG = −0.23 [2.35], P = .96), negative affect under 
OXT (mean [SD] of EG = 0.50 [2.12], IG = −0.30 [1.70], P = .55), or neg-
ative affect under placebo (mean [SD] of EG = 0.50 [0.70], IG = 0.07 
[1.70], P = .74). The included subjects were well matched for the 
total proportion of frames, with displacement >0.5 mm in either 
arm of the study (proportion of frames [SD] displaced after OXT 
=  13.5% [14%]; PLA = 13.2% [16%]; within-subjects F = 0.013, P = .91) 
and for the mean displacement across the 3 translation and 3 
rotation axes, quantified in accordance with Power et al. (2012) 
(frame-wise displacement [SD] after OXT = 0.34 [0.21]; PLA = 0.47 
[0.75]; within-subjects F = 0.78, P  =.39).
Derived Measures of Connectivity
As our primary hypothesis was related to the influence of OXT 
on the Fc of the amygdala, right and left Automated Anatomical 
Labelling (AAL) masks were used separately to compute Fc 
(Tzourio-Mazoyer et al., 2002). Pearson’s correlation coefficients 
were computed between the mean time-series of all voxels 
included within each region of interest and every voxel in the 
brain for each subject. The correlation coefficients were normal-
ized using Fisher’s r-to-z transformation.
To compute DC, for each voxel (i), a value representing the 
number of voxels in the rest of the brain showing a correlation 
above a specified threshold (absolute value of r >  0.25) with (i). 
This threshold was chosen in line with previous work (Buckner 
et al., 2009; Palaniyappan and Liddle, 2014; Zhou et al., 2014) and 
represents an effect size that eliminates counting of voxels with 
low temporal correlation that may result from noise in resting 
fMRI (Buckner et al., 2009). The DC and ReHo maps were z-trans-
formed using respective mean values obtained from all voxels 
contained within subject-specific grey matter masks. For DC, Fc, 
and ReHo measures, voxelwise paired t tests with a family-wise 
error (FWE) cluster-wise correction (P < .05) and an inclusion 
threshold of P < .05 were undertaken to study group-level differ-
ences between OXT and placebo trials.
Results
OXT significantly reduced the DC in a single cluster centered 
on the right precuneus (Montreal Neurological Institute (MNI) 
coordinates of the peak of the significant cluster  =  18, −60, 27; 
FWE-corrected P = 0.015, 1113 voxels). There were no other signifi-
cant changes in DC with OXT, though at a more lenient statisti-
cal threshold (peak intensity T = 2.3, extent k = 50 voxels), other 
regions showing altered DC were noted (Supplementary Material).
OXT significantly reduced the Fc between bilateral amyg-
dala seeds and a single cluster that included the right precu-
neus (left amygdala seed: MNI coordinates of the peak of the 
significant cluster = 18, −60, 27; FWE corrected P = .026, 1806 vox-
els; right amygdala seed: MNI coordinates of the peak of the sig-
nificant cluster = 15, −45, 3; FWE corrected P < .001, 1267 voxels). 
These clusters are shown in Figure 1. OXT did not produce any 
other significant changes in Fc of the amygdala compared with 
Figure 1. Effect of oxytocin (OXT) on the functional connectivity of the left and right amygdala. Clusters showing a decrease in functional connectivity with the left 
amygdala (blue) and right amygdala (red-yellow) under OXT administration compared with placebo. Regions in green show reduced connectivity with both right and 
left amygdala (overlap). The clusters that survived correction for multiple testing were centred around MNI coordinates 18, −60, 27 (1806 voxels, FWE corrected P = .026) 
for right amygdala and 15, −45, 3 (1267 voxels, FWE corrected P < .001) for left amygdala, both corresponding to right precuneus. To display the extended distribution 
of this cluster a height threshold T = 2.3 and an extent threshold k = 50 are used in this figure. Other regions showing a differential effect of OXT at this threshold 
(T = 2.3,k = 50) are displayed in Supplementary Tables 3 and 4. The statistical maps are displayed on a template structural image provided with MRICRON software.
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placebo, though at a more lenient statistical threshold (peak 
intensity T = 2.3, extent k = 50 voxels), other regional changes in 
Fc were also noted (Supplementary Material).
The ReHo analysis did not yield any significant results at the 
whole brain level. At a more lenient statistical threshold (peak 
intensity T = 2.3, extent k = 50 voxels), regional changes in ReHo 
were notable (Supplementary Material). When a posthoc search 
within bilateral amygdala was conducted, a significant reduc-
tion in the ReHo was noted in the right amygdala in OXT trials 
compared with the placebo (MNI coordinates of the peak of the 
significant cluster = 30, 3, −21; few-corrected peak level P = .036, 
T = 3.64), but no significant changes in ReHo were observed in 
the left amygdala. A similar posthoc analysis of ReHo changes 
within the Automated Anatomical Labelling precuneus masks 
did not produce any significant results.
OXT did not have any significant effect on positive or nega-
tive affect. These results are presented in Table 1.
Discussion
Using resting state fMRI connectivity analysis, we investigated 
the neurophysiological effect of OXT administration in healthy 
male volunteers. Our results indicate that intranasal OXT affects 
one of the core centers in the brain that is crucial for social cog-
nition and introspective processing: the precuneus. The precu-
neus is a part of the DMN, with an important role in mentalizing 
and self-referencing, thus forming a constituent part of the so-
called social brain (Mars et al., 2012; Cabanis et al., 2013; Amft 
et al., 2014; Utevksy et al., 2014). OXT not only reduced the con-
nectivity between bilateral amygdala and the precuneus but 
also resulted in a generalized reduction in the connectivity of 
the precuneus. In addition, OXT also reduced the localized con-
nectivity of right amygdala.
In this study, the DC of the right precuneus was significantly 
reduced after the administration of OXT. In normal circum-
stances, several regions including the precuneus act as hubs 
that show a high DC. These hubs are highly connected to many 
other regions in the brain, potentially facilitating the integration 
of connectivity between spatially distinct functional systems 
(Buckner et al., 2009). A single dose of OXT shows the potential 
to affect this intrinsic systems-level hub architecture, at least for 
a short time, by reducing the centrality of one of the core hubs.
Our results also show that OXT affects the localized con-
nectivity of the amygdala, as measured by ReHo, which reflects 
the temporal synchrony of the BOLD response within a particu-
lar region and is a measure of intraregional brain connectivity. 
A  number of neuroimaging studies involving facial emotion 
processing tasks implicate the modulation of amygdala as 
a key effect of OXT administration (Meyer-Lindenberg et  al., 
2011; Riem et  al., 2012). In general, these studies suggest that 
OXT “dampens” the activity of amygdala and thus may have a 
prosocial effect by either reducing negative reactions to social 
cues and/or reducing (aversive) associative learning in response 
to socially relevant cues (Petrovic et al., 2008). Our observation 
of reduced localized connectivity (ReHo) in amygdala in repose 
to OXT suggests that the amygdala-modulating effect of OXT 
occurs even in the absence of emotion-processing constraints.
We also observed a dissociation (decreased connectivity) 
between the amygdala and the precuneus hub in response to 
OXT. In the absence of socially relevant external stimuli, the 
dissociation of amygdala from the task-negative, DMN region 
(precuneus) may reduce the involvement of amygdala-related 
activity in internal mentation (Andrews-Hanna, 2012) or associ-
ative memory processes in which precuneus plays an important 
role (Murray and Kensinger, 2014). It is important to note that 
the connectivity of precuneus and amygdala increases during 
social task-processing (exposure to infant laughter) in female 
volunteers exposed to OXT compared with placebo (Riem et al., 
2012). These 2 observations when taken together suggest that 
OXT modulates the interaction between amygdala and precu-
neus in a context-specific manner.
Our results are particularly relevant in light of the fact that OXT 
is now being considered as a treatment option for a number of 
conditions. For instance, an increase in DC in the precuneus was 
found in individuals with autistic spectrum disorders and atten-
tion deficit hyperactivity disorder (Di Martino et al., 2013). Similarly, 
abnormalities in the resting-state Fc between the amygdala and 
precuneus have been observed in anxiety-related disorders. Higher 
connectivity between amygdala and precuneus was shown to be 
correlated with current post-traumatic stress disorder (PTSD) 
symptoms and was also a predictor of PTSD after a trauma (Lanius 
et al., 2010), whereas an increase in Fc between these 2 regions 
was found in patients with panic disorder (Pannekoek et al., 2013). 
Comparing these outcomes with the results obtained from our 
study (ie, a reduction in DC of the right precuneus and a decrease 
in Fc between the amygdala and the precuneus), it appears as if 
the mechanistic process by which OXT potentially improves social 
cognition is by acting on these altered connections within the lim-
bic/social-affective network seen in these disorders.
Despite a similar protocol and the same dose of OXT, results 
obtained from this study do not correspond with those reported 
in the one other paper on the resting-state Fc of OXT in healthy 
males (Sripada et al., 2013). Even when we undertook a motivated 
search within the small volume of a 6-mm sphere centered on 
Table 1. Effect of OXT on Positive and Negative Affect
Baseline Score 
Between-Subject 
Mean (SD)
After-Effect 
Between-Subject 
Mean (SD)
Change Score (After-Effect 
Minus Baseline)  
Within Subject Mean (SD)
Paired Samples  
T Test  
Change Score
OXT positive affect 30.31 (5.31) 31.00 (6.96) 0.69 (4.15) P = .43
Placebo
Positive affect
30.38 (5.33) 30.15 (7.18) −0.23 (2.35)
OXT negative affect 11.92 (2.25) 11.62 (2.69) −0.30 (1.70) P = .55
Placebo
Negative affect
13.08 (5.46) 13.15 (4.96) 0.07 (1.70)
Abbreviation: OXT, oxytocin.
Positive and negative affect scores were calculated using the Positive and Negative Affect Schedule (PANAS). PANAS was administered upon arrival (baseline score) 
and 45 min after intranasal spray administration (after-effect score). The change score was calculated by subtracting the after-effect score from the baseline score 
for each subject individually. These within-subject change scores for OXT and placebo were then used to perform 2 paired samples t tests (one each for positive and 
negative affect) to test whether there were any significant differences in the change in affect as a result of OXT administration.
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the coordinates identified by Sripada et al. (MNI coordinates: −4, 
32, −4; small volume correction (SVC) search FWE corrected at 
threshold P < .05), we did not observe any OXT-related increase 
in connectivity from either amygdalae seeds. Reasons for this 
could be differences in acquisition times and preprocessing strat-
egies. In Sripada et al.’s (2013) study, the resting-state acquisition 
lasted only 3 minutes, whereas our study used a 5-minute–long 
paradigm. Although short scanning period need not necessarily 
induce or reduce connectivity, it has been shown that this results 
in poor reliability of connectivity patterns (Birn et  al., 2013). 
Additionally, we used a stringent head-motion correction (Friston 
24) followed by correction for micro-movements using scrubbing 
(Power et  al., 2012). Lack of appropriate motion correction has 
been associated with the appearance of spurious connectivity 
patterns (Power et al., 2012). In contrast to Sripada et al. who used 
EPI normalization, we used DARTEL-based spatial normalization. 
EPI normalization could affect group-level statistics, particularly 
in brain regions where signal dropouts do not match the EPI tem-
plate (eg, the ventromedial prefrontal regions where the main 
effect was observed by Sripada et al.) (Huang et al., 2010). This may 
induce localization errors, reducing both the detection sensitiv-
ity and repeatability of reported group differences in connectiv-
ity metrics. The observation that the precuneus shows an overall 
reduction in connectivity indexed by DC as well as reduced con-
nectivity with amygdala seed region when OXT is administered 
adds validity to our report. Despite the differences from Sripada 
et al. (2013), there is a broad agreement between both studies in 
that the resting-state amygdala connectivity is altered after OXT 
administration. Interestingly, results similar to ours have been 
observed with the administration of allopregnanolone in healthy 
volunteers (Sripada et  al., 2014). Allopregnanolone is a neuro-
steroid that has been shown to modulate OXT expression in rats 
(Blyth et al., 2000; Widmer et al., 2003), and it appears as though 
the neurophysiology of allopregnanolone is closely linked to that 
of OXT. Studies focusing on both the precuneus and amygdala 
are likely to provide better insights into the network-level mecha-
nism by which OXT affects affiliative behavior.
Several limitations need to be taken into account when inter-
preting our reported findings. The sample size in this study was 
quite small, and studies with larger sample sizes would need to 
be carried out in order to determine whether or not the results 
obtained from this study are robust and can be replicated. Several 
brain regions that have previously been implicated in social 
cognition and OXT-mediated effects showed a trend towards 
altered centrality and ReHo but were not sufficiently large in 
effect to survive the correction for multiple comparisons in this 
sample. These results, reported in the Supplementary Material, 
will require further inspection in larger samples. Moreover, as 
this study included only male volunteers, we cannot generalize 
these findings to females. Results from a resting-state Fc study 
of the influence of OXT on females showed no effect of OXT on 
the Fc of the amygdala (Riem et al., 2013). Hence, it is important 
to note that intranasal OXT might have varied neurophysiologi-
cal effects on males and females.
OXT is a promising agent currently being tested for clini-
cal efficacy for the affiliative dysfunctions seen in a variety 
of psychiatric disorders (Bora et al., 2009). Most of these trials 
involve the administration of oXT as a therapeutic agent with-
out any explicit social-cognitive training in combination. Thus, 
understanding the “resting-state” effects of OXT is crucial to 
evaluate the mechanisms that are likely to underlie the clini-
cal responses observed upon regular administration of OXT. The 
lack of a mechanistic understanding of how novel therapeutic 
agents work has been highlighted as an important hurdle in the 
successful development of new treatment approaches (Insel 
et  al., 2013). This study adds to our current understanding of 
how OXT can modulate brain networks at rest and raises the 
possibility for a wider role for OXT in disorders of connectivity 
involving the core hubs of human connectome.
Supplementary Material
For supplementary material accompanying this paper, visit 
http://www.ijnp.oxfordjournals.org/
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